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ABSTRACT
Background: Insulinomas are tumors of the pancreatic islet beta cells that secreting insulin. They are malignant neoplasms 
and rarely seen in dogs. Because insulinomas secrete excessive insulin and hypoglycemia occur. The most common clini-
cal symptoms are seizures, extreme weakness, and other neurological abnormalities. The tumors typically release insulin 
episodically, with clinical signs being seen intermittently as a result. These are most often associated with prolonged 
starvation or prolonged periods of exertion. Insulinoma occurs most often in middle-aged and older dogs, averaging nine 
years in age. They affect both sexes and are more likely in larger breeds. The most commonly afflicted breeds are German 
Shepherds, Irish Setters, Boxers, Golden Retrievers and Terriers.
Case: In this study, a case of malignant insulinoma with multiorgan metastasis in a 7-year-old hunting dog that brought to 
the clinic with complaints of constipation and inappetence were evaluated by clinical, cytological, histopathological and 
immunohistochemical findings. Owner stated that the animal suffers from constipation for 4 days, but no vomitus or ner-
vous symptoms were present. Clinical efforts not solved the constipation. For to the definitive diagnosis the dog decided to 
underwent laparotomy. After a midline abdominal approach multiple whitish, hard and irregular metastatic tumoral masses 
were observed in different abdominal organs. Because of the poor prognosis and according to owner’s acceptance the 
dog euthanatized at the same time. At necropsy, a bloody serous fluid approximately 500 mL was found in the abdominal 
cavity. The intestines were hyperemic and hemorrhagic in some areas. A hemorrhagic 9x5x3 cm in diameter mass was 
observed on the pancreas. Mesenterial adhesions were formed due to mass between duodenum and jejunum. The mass 
was moderately hard and cut surface was bloody, necrosis was observed in some areas. At the gross examination, whitish 
color, various sized and multiple metastatic masses were noted in spleen, liver, lymph nodes and lungs. Before formalin 
fixation, impression smears were made from the pancreatic mass. In cytological preparations of the lesion, epithelial cells 
in different shapes and sizes were observed. At the histopathological examination, the tumor mass consisted of anaplastic, 
pleomorphic cells that have pale cytoplasm, vesicular nucleus and prominent nucleolus. Diffuse necrotic areas were noted 
in the mass. Similar metastatic masses were seen in liver, spleen, lungs and kidneys. The tumor cells were positive for 
insulin and negative for glucagon immunohistochemically.
Discussion: Insulinomas generally caused nervous symptoms due to hypoglycemia. Metastasis may occur in some cases 
and generally lymph node metastasis occurs. Spleen metastasis are very rare in insulinoma cases. The mean age of the 
occurrence of insulinoma is generally older than 9-year-old. In this case, a case of malignant insulinoma with multiorgan 
metastasis and caused constipation due to intestinal adhesions in a dog was presented with clinical and pathological find-
ings. Best of the author’s knowledge insulinoma as a cause of constipation not previously reported in a dog. The aim of 
this study was to report a case of metastatic insulinoma without neurological symptoms but constipation in a 7 years old 
hunting dog by clinical, pathological, cytological and immunohistochemical findings.
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INTRODUCTION
Occurrence of primary pancreatic neoplasm 
is relatively rare in dogs [5,11,13]. The most of the 
pancreatic neoplasms are derived from acinar or pan-
creatic duct epithelial cells of exocrine pancreas. The 
exocrine pancreatic neoplasm is usually diagnosed as 
malignant tumors. Transcoelomic, local invasive and 
long distant metastasis are usually occurred before the 
onset of clinical signs [1,3,4,6].
Clinical symptoms are secondary to hypo-
glycemia, and commonly include neuromuscular 
findings. The severity of clinical signs depends upon 
the duration and severity of hypoglycemia and the 
rate at which the blood glucose concentration falls. 
When fasting hypoglycemia is recurrent or per-
sistent, adaptation permits tolerance of extremely 
low blood glucose levels without obvious clinical 
signs. Generally, clinically functional insulinomas 
associated with a syndrome of hyperinsulinism and 
hypoglycemia caused neurologic symptoms such as 
episodic seizures, weakness, ataxia, mental confu-
sion, depression and collapse [1,4,6-10,15,16]. These 
clinical signs reflect both inadequate glucose supply 
to the central nervous system and increased catechol-
amine secretion by the adrenal medulla in response 
to hypoglycemia [8-11,15,16]. Uncommon manifes-
tations of insulinomas in dogs include weight gain, 
due to the anabolic effects of insulin, and persistent 
insomnia. In a minority of affected animals, periph-
eral polyneuropathy develops and is characterized by 
demyelination, remyelination, and, to a lesser extent, 
axonal degeneration [1].
Aggressive behavior of insulin secreted tu-
mors is diagnosed by their histological appearance, 
in malignant cases the cells may be less uniform in 
size and shape than in benign ones. Demonstration 
of vascular or lymphatic invasion, the most important 
criterion of malignancy, may require examination 
of multiple sections. Adenomas are slow-growing, 
sharply delineated, and encapsulated, and are ame-
nable to surgical excision [1].
The aim of this study was to present, a case 
of malignant insulinoma with multiorgan metastasis 
in a dog suffer from constipation and inappetence 
that previously not documented clinical symptom 
as insulinomas were evaluated by clinical, cytologi-
cal, histopathological and immunohistochemical 
findings.
CASE
A 7-year-old hunting dog presented to the clinic 
with complaints of constipation and inappetence during 
for 4 days. Clinical efforts not solved the constipation. 
After clinical examination dog was decided to laparotomy. 
During the operation multiple masses were observed in 
liver, lymph nodes and spleen. A big tumoral mass that 
caused the adhesions at gut was observed in pancreas. 
Because of the poor prognosis the dog was euthanatized 
and necropsy performed. During the necropsy in addition 
to liver, lymph nodes and spleen multiple tumoral masses 
were also observed at lungs. Impression smears were 
prepared from the tumoral mass and stained with Giemsa 
method. Tissue samples from tumoral mass and all visceral 
organs were collected and fixed 10% buffered formalin for 
histopathological examination. After routine pathology 
procedure tissue samples embedded the paraffin and cut 5 
µm thicknesses. Sections stained with hematoxylin-eosin 
and examined under light microscope. After histopatho-
logical examination selected tissue sections were then 
immunostained with insulin antiserum (Anti-insulin+ 
Proinsulin antibody, [D6D4] (ab8304), 1/100 dilution)1 
and glucagon antiserum (Anti-glucagon antibody, 
(ab8055), 1/100 dilution)1 according the manufacturer’s 
instructions using a routine streptavidin- biotin peroxidase 
technique. Streptavidin-biotin immunoenzymatic antigen 
detection system [EXPOSE Mouse and Rabbit Specific 
HRP/DAB Detection IHC kit (ab80436)]1 was used as a 
second antibody. The antigens were demonstrated by using 
diaminobenzidine (DAB) as the chromogen.
Clinical examination revealed severe abdomi-
nal distension and mild respiratory distress. The dog 
was reluctant to move. Diffuse loss of detail without 
free air observed radiographically. According to clini-
cal findings and owners’ acceptance laparotomy was 
performed. Because of diffuse multiple macroscopical 
masses seen after midline abdominal approach eutha-
nasia performed at the same time.
Necropsy revealed, approximately 500 mL bloody 
serous fluid in the abdominal cavity. The intestinal walls 
and mesenterial vessels were hyperemic. Hemorrhagic and 
necrotic areas were in seen in intestine.  A firm, whitish-
pink color, hemorrhagic and necrotic 9x5x3 cm in diameter 
mass was observed on the caudal part of pancreas. Cut 
surface of the mass was bloody, and big necrotic areas 
were observed. Mesenterial adhesions were formed due to 
mass between duodenum and jejunum. Intestinal content 
full fill the gut lumen before the adhesion area.
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At the gross examination, firm, various sized 
and whitish in color multiple metastatic masses were 
seen in spleen, liver, lymph nodes and lungs (Figure 1). 
In addition to multiple metastatic nodules in different 
organs, kidneys were pale and had degenerative changes.
In cytological preparations of the lesion, epi-
thelial cells in different shapes and sizes were observed. 
Giemsa stained cells had scant cytoplasm, big irregular 
nuclei and marked nucleoli. Numerous degenerative 
and necrotic cells were also noticed in the smear. In 
addition to tumoral cells marked inflammatory cells 
mainly composed of neutrophil leukocytes and lym-
phocytes were observed (Figure 2.D).
At the histopathological examination, sections 
prepared from pancreatic mass revealed multilobulated 
tumor nodules composed mainly of epithelial cells 
arranged in tubuloalveolar and papillary patterns with 
occasionally lumen formation. The mass had abundant 
fibrous septa that give lobular appearance to the tis-
sue. The tumor consisted of anaplastic, pleomorphic 
cells that have granular eosinophilic cytoplasm. These 
cells had variably sized, irregular nuclei, vesicular and 
prominent nucleolus. Diffuse necrotic areas were noted 
in the mass. Higher mitotic activity was observed in 
both primary tumoral mass and metastatic foci. Accord-
ing the findings histopathological diagnosis of exocrine 
pancreatic carcinoma was made (Figure 2A-B).
Tumoral cells were strongly positively im-
munostained with insulin and negative for glucagon. 
Intensive staining was observed in primary tumor that 
metastatic masses. Localization of the staining was cy-
toplasmic and generally diffuse in some cells granular 
staining was also observed (Figure 2C).
DISCUSSION
Although pancreatic tumors rarely occur, 
insulinoma is the most common islet-cell neoplasia 
in dogs [1,4,7]. A definitive diagnosis of insulinoma 
requires histopathological evidence of a tumor in tissue 
samples [6,9,14]. In this case, a definitive diagnosis of 
insulinoma were made by cytological, histopathologi-
cal and immunohistocemical examination.
Clinically functional insulinomas associated 
with a syndrome of hyperinsulinism, episodic hypo-
glycemia, and neurologic signs. Signs of sympathetic 
nervous system stimulation include trembling, muscle 
fasciculations, restlessness, hunger, and behavioral 
changes and often precede signs of neuroglycopenia 
[1,4]. In present case, the dog presented to the clinics 
complains of constipation and in appetence. There was 
no nervous symptom that thought to the insulinoma.
Most insulinomas are small, measuring 1 cm 
or less in diameter, so that a thorough search for a 
suspected tumor is necessary. Intraoperative identifica-
tion may be facilitated by intravenous administration 
of methylene blue that becomes concentrated in the 
endocrine pancreas [1]. In this case, the tumor was 
9x5x3 cm in diameter and this tumor was very big and 
metastases of the tumor were numerous. It is possible 
Figure 1. A- Gross appearance of the metastatic tumoral masses 
during laparotomy. B- Metastatic tumoral masses in liver, spleen 
and lungs (arrows) after necropsy. C- Gross appearance of the 
insulinoma (arrows). D- Cut surface of the insulinoma.
Figure 2. A- Histopathological appearance of the insulinoma and 
numerous insulin secreted cells (arrows), HE [Bar= 50 µm]. B- 
Liver metastases of the insulinoma (arrows), HE [Bar= 200 µm]. 
C- Insulin positive cells (arrows) by immunohistochemical staining, 
streptavidin biotin method [Bar= 50 µm]. D- Impression smear of 
the tumoral masses and numerous insulin secreted epithelial cells 
(arrows), Giemsa staining [Bar= 100 µm].
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to assess the tumor very aggressive and malign for its 
pathological findings.
Most insulinomas in animals are generally has 
malignant behavior and locally invasive Early metas-
tasis to regional lymph nodes and liver commonly 
observe at diagnosis [3,10,15,16]. In addition, metas-
tases to peritoneal surface, other abdominal organs and 
lung may be seen. Distant metastasis to other organs, 
such as vertebrae, femur, intracranial, tonsil esophagus 
and submandibular lymph nodes also documented 
[2,4,11]. Carcinomas may be larger than adenomas 
and may have a multilobular appearance and contain 
foci of hemorrhage and necrosis [1]. In agreement in 
this study with previous studies, our case was very big 
and aggressive than literature knowledge. Metastases 
were observed interestingly spleen that very rare site of 
insulinoma metastases in addition to the lymph nodes, 
lungs and livers.
Insulinomas are usually diagnosed in middle-
aged to older dogs, without sex predisposition. Large 
breeds encountered as predisposed factor but this tu-
mor may occur in any breed [2,6,8-10,12,14,17]. We 
reported insulinoma in a 7-year- old hunting dog with 
totally agreement previous documented cases.
This study reported a case of malign insuli-
noma with multiorgan metastasis in a 7-year-old dog 
that suffer from constipation and in appetence.  These 
clinical symptoms not previously reported in insuli-
noma cases previously. Although the tumor was very 
big and aggressive clinical symptoms were unrelated 
the classical insulinoma cases.
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